| Metric | Q1 FY27 | Q1 FY26 | Q4 FY26 |
|---|---|---|---|
| Revenue from operations | 29.2 | 17.3 | 26.7 |
| Other income | 0.2 | 0.1 | 0.8 |
| Total income | 29.4 | 17.4 | 27.6 |
| Profit before exceptional items & tax | 2.6 | -0.6 | 1.3 |
| Profit before tax | 2.6 | -0.6 | 1.3 |
| Net profit | 1.6 | -0.6 | 1.0 |
| Operating margin | 8.8% | -3.4% | 4.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +60.00% |
|---|---|
| Revenue, year on year | +9.40% |
| Operating profit, year on year | +380.00% |
| Operating profit, quarter on quarter | +442.90% |
NSE results filing, NSE: NEPHROCARE. Figures extracted from the filing.
Nephro Care India Ltd: key numbers
- Share price
- ₹87.30
- Market cap
- ₹143.9 Cr
- Revenue (annual)
- ₹88.73 Cr
- Net profit (annual)
- ₹3.37 Cr
- P/E (TTM)
- 42.7×Sector 53.1×
- Promoter holding
- 61.71%+0.00% QoQ
- FII holding
- 0.96%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nephro Care India Ltd
All →Nephro Care India Adverse Business Impact
Nephro Care India closes its Salt Lake, Kolkata dialysis unit from September 15, 2026 due to licensing constraints. Operations cease and premises will be vacated.
Nephro Care India Annual General Meeting
Nephro Care India Limited submitted its Annual Report for FY 2025-26 and the Notice for its 12th Annual General Meeting scheduled for September 25, 2026.
Nephro Care India Other Announcement
Nephro Care India Limited submitted its Statement of Deviation or Variation regarding IPO issue proceeds for the quarter ending June 30, 2026, confirming no deviations.
Nephro Care India Legal & Regulatory
Nephro Care India Limited informs that SEBI corporate governance regulations do not apply to it for Q June 2026. The filing records this compliance exemption.
Nephro Care India Results Correction
Nephro Care submitted revised half‑yearly audited financial results, reporting total income of ₹2,674.63 crore. The filing addresses the exchange’s clarification request.
- Value
- ₹2,675 Cr
Nephro Care India Fund Raise of ₹33.72 Cr
Nephro Care India confirmed the utilization of ₹33.72 Crore from IPO proceeds through March 2026. Funds were deployed for hospital setup and corporate purposes.
- Value
- ₹33.72 Cr